Search
for
Sort by
Research 241–270 of 781
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- New Modalities in the Treatment of Refractory Alopecia Areata
- Vitiligo—Current Treatment Options and Future Perspectives
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Resident Memory T Cells in Autoimmune Skin Diseases
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Autoinmune Alopecia/Alopecia Areata
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- 705 Particulate matter induces inflammatory response in human outer root sheath cells via oxidative stress-dependent MAPK and JAK-STAT signaling pathways
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Targeted immunotherapy for hair regrowth and regeneration
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance